Search

Your search keyword '"P. Basilicata"' showing total 76 results

Search Constraints

Start Over You searched for: Author "P. Basilicata" Remove constraint Author: "P. Basilicata" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
76 results on '"P. Basilicata"'

Search Results

1. The GAPS programme at TNG -- LXIII. Photo-evaporating puzzle: Exploring the enigmatic nature of TOI-5398 b atmospheric signal

4. Star-spot activity, orbital obliquity, transmission spectrum, physical properties, and TTVs of the HATS-2 planetary system

5. The GAPS Programme at TNG LV. Multiple molecular species in the atmosphere of HAT-P-11 b and review of the HAT-P-11 planetary system

12. The GAPS Programme at TNG. XLI. The climate of KELT-9b revealed with a new approach to high spectral resolution phase curves

13. The GAPS Programme at TNG XL: A puffy and warm Neptune-sized planet and an outer Neptune-mass candidate orbiting the solar-type star TOI-1422

14. The GAPS Programme at TNG: XXXVI. Measurement of the Rossiter-McLaughlin effect and revising the physical and orbital parameters of the HAT-P-15, HAT-P-17, HAT-P-21, HAT-P-26, HAT-P-29 eccentric planetary systems

15. MSL2 ensures biallelic gene expression in mammals

25. A Comprehensive In Vitro Characterization of a New Class of Indole-Based Compounds Developed as Selective Haspin Inhibitors.

27. In Silico Assisted Identification, Synthesis, and In Vitro Pharmacological Characterization of Potent and Selective Blockers of the Epilepsy-Associated KCNT1 Channel.

29. De novo mutations in MSL3 cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation

32. Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute Pancreatitis.

34. Discovery and Optimization of Indoline-Based Compounds as Dual 5‑LOX/sEH Inhibitors: In Vitro and In Vivo Anti-Inflammatory Characterization.

35. Beyond Retigabine: Design, Synthesis, and Pharmacological Characterization of a Potent and Chemically Stable Neuronal Kv7 Channel Activator with Anticonvulsant Activity.

36. RNA stability controlled by m6A methylation contributes to X-to-autosome dosage compensation in mammals

37. Discovery and Optimization of Indoline-Based Compounds as Dual 5-LOX/sEH Inhibitors: In Vitroand In VivoAnti-Inflammatory Characterization

38. Impact of SARS-CoV-2 on dentistry: a review of literature.

39. Illicit drugs seizures in 2013–2018 and characteristics of the illicit market within the Neapolitan area

40. Application of a chemiluminescence immunoassay system and GC/MS for toxicological investigations on skeletonized human remains

41. Proteomics in Forensic Sciences: Identification of the Nature of the Last Meal at Autopsy

42. Exploration of TRPM8 Binding Sites by β‑Carboline-Based Antagonists and Their In Vitro Characterization and In Vivo Analgesic Activities.

43. Synthesis and Pharmacological Characterization of Conformationally Restricted Retigabine Analogues as Novel Neuronal Kv7 Channel Activators

45. A Comprehensive In VitroCharacterization of a New Class of Indole-Based Compounds Developed as Selective Haspin Inhibitors

46. In SilicoAssisted Identification, Synthesis, and In VitroPharmacological Characterization of Potent and Selective Blockers of the Epilepsy-Associated KCNT1 Channel

47. De novo mutations in MSL3cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation

48. Green Roof Effects in a Case Study of Rome (Italy).

49. Assessment of the Impact of a Centralized Heating System Equipped with Programmable Thermostatic Valves on Building Energy Demand.

50. Enhancer cooperativity as a novel mechanism underlying the transcriptional regulation of E-cadherin during mesenchymal to epithelial transition.

Catalog

Books, media, physical & digital resources